About the Authors
- Hideaki Sueoka
-
Affiliation Genomic Science Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554–0022, Japan
- Junji Ichihara
-
Affiliation Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 33–94 Enokicho, Suita, Osaka 564–0053, Japan
- Takahiro Tsukimura
-
Affiliation Department of Functional Bioanalysis, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204–8588, Japan
- Tadayasu Togawa
-
Affiliation Department of Functional Bioanalysis, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204–8588, Japan
- Hitoshi Sakuraba
-
* E-mail: sakuraba@my-pharm.ac.jp
Affiliation Department of Clinical Genetics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204–8588, Japan
Competing Interests
Although the study received funding from a commercial source (Sumitomo Dainippon Pharma Co., Ltd.), this funding was solely for research activity, and was not used for employment, consultancy, patents, products in development, or marketed products related to commercial sources. Although H. Sueoka and J. Ichihara are employees of Sumitomo Dainippon Pharma Co., Ltd., they have no competing interest. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials. All authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: H. Sueoka JI T. Tsukimura T. Togawa H. Sakuraba. Performed the experiments: H. Sueoka JI. Analyzed the data: H. Sueoka JI H. Sakuraba. Contributed reagents/materials/analysis tools: H. Sueoka JI T. Tsukimura T. Togawa H. Sakuraba. Wrote the paper: H. Sueoka JI T. Tsukimura T. Togawa H. Sakuraba.